Literature DB >> 1614249

Hearing preservation in acoustic neuroma surgery: a continuing study.

M D Atlas1, C Harvey, P A Fagan.   

Abstract

Hearing preservation in acoustic neuroma surgery is possible in a limited number of cases. Although there have been many articles published about hearing preservation, there have been few studies of long-term hearing results, nor is it known if there is an increased rate of tumor recurrence when hearing preservation is attempted. Twenty-two patients who underwent a hearing preservation procedure via the retrosigmoid approach were selected from 80 consecutive patients with cerebellopontine angle tumors operated on from February 1984 to November 1987. Useful hearing was retained in 11 cases as reported in a previously published study. Seven patients continue to have useful hearing after 3 to 5 years; 3 have shown a gradual but slight decline. There has been no tumor recurrence in these patients, but 2 patients, operated on early in the series and who had lost hearing, had recurrent tumor.

Entities:  

Mesh:

Year:  1992        PMID: 1614249     DOI: 10.1288/00005537-199207000-00007

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  4 in total

Review 1.  [Cerebellopontine angle surgery. Part 2: Specific remarks].

Authors:  B Schaller
Journal:  HNO       Date:  2003-03-28       Impact factor: 1.284

2.  Hearing preservation surgery in acoustic neuroma: long-term results.

Authors:  A Mazzoni; E Zanoletti; V Calabrese
Journal:  Acta Otorhinolaryngol Ital       Date:  2012-04       Impact factor: 2.124

3.  Long-term hearing outcome after retrosigmoid removal of vestibular schwannoma.

Authors:  Akira Nakamizo; Megumu Mori; Daisuke Inoue; Toshiyuki Amano; Masahiro Mizoguchi; Koji Yoshimoto; Tomio Sasaki
Journal:  Neurol Med Chir (Tokyo)       Date:  2013-09-27       Impact factor: 1.742

4.  Usefulness of the radiological planning for hearing preservation surgery in vestibular schwannoma.

Authors:  Kamil Krystkiewicz; Tymon Skadorwa; Paweł Szaro; Bogdan Ciszek
Journal:  Surg Radiol Anat       Date:  2016-03-22       Impact factor: 1.246

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.